Cite
MLA Citation
Kleanthis Manousaridis and James Talks. “Two Week, OCT-Based follow-up as Guidance for Retreatment with Ranibizumab for CNV Apparently Refractory to Therapy.” European journal of ophthalmology, vol. 25, no. 3, 2015, pp. 235–240. http://access.bl.uk/ark:/81055/vdc_100073354007.0x00002d